Donald J. Santel

Chief Executive Officer, COTHERIX INC.

Companies

Jade Biosciences, Inc.Board member Jan 23, 2023 to Jun 7, 2024¹
Oyster Point Pharma, Inc.Board member Aug 3, 2021 to Jan 4, 2023²
Surrozen, Inc./DEBoard member Nov 18, 2020 to Nov 18, 2020³
Anthera PharmaceuticalsBoard member Feb 23, 2010 to Jul 5, 2011⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Oyster Point Pharma, Inc.0 shares⁵Jan 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 3, 2023Returned to company 8,198 shares of Oyster Point Pharma, Inc.⁵
Jan 3, 2023U 5,489 shares of Oyster Point Pharma, Inc.⁵
Jun 6, 2022Granted 3,573 shares of Oyster Point Pharma, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJade Biosciences, Inc., Board member
2
SEC EDGAROyster Point Pharma, Inc., Board member
3
SEC EDGARSurrozen, Inc./DE, Board member
4
SEC EDGARAnthera Pharmaceuticals, Board member
5
SEC EDGAROyster Point Pharma, Inc. shares after the filing of Jan 3, 2023
6
SEC EDGARForm 4 filed Jun 8, 2022